Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

DINESH KAPUR

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1538144522
CMS profile
115187
Location
NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$9,650.92

198 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Page 2 of 4; records 51–100 of 198 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

DINESH KAPUR

NPI 1538144522 · CMS profile ID 115187

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

NORWICH, CT

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 4; records 51–100 of 198 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1538144522?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
DINESH KAPUR, NPI 1538144522, CMS profile ID 115187. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 198 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1538144522?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). DINESH KAPUR, NPI 1538144522, CMS profile ID 115187. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 4; records 51–100 of 198 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1538144522?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
DINESH KAPUR, NPI 1538144522, CMS profile ID 115187, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 4; records 51–100 of 198 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1538144522?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

198 matching records · $9,650.92 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 198 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 198.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Celgene Corporation $21.1110/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184894432 CMS
GENZYME CORPORATION $19.4710/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233288289 CMS
ABBVIE INC. $26.8710/10/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202159562 CMS
Gilead Sciences, Inc. $34.1110/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234419679 CMS
BeOne Medicines USA, Inc. $29.2910/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202885182 CMS
GlaxoSmithKline, LLC. $28.1710/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1190378631 CMS
Alexion Pharmaceuticals, Inc. $19.1409/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202966030 CMS
Novartis Pharmaceuticals Corporation $27.8609/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200312110 CMS
Rigel Pharmaceuticals, Inc. $26.2409/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1247377907 CMS
AstraZeneca Pharmaceuticals LP $23.7209/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1206683580 CMS
SERVIER PHARMACEUTICALS LLC $22.0209/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229096156 CMS
Geron Corporation $24.1509/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238889756 CMS
PFIZER INC. $22.6209/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230323279 CMS
Celgene Corporation $13.8609/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184894420 CMS
Bayer Healthcare Pharmaceuticals Inc. $19.1609/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1225599090 CMS
SOBI, INC $17.8209/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1240257959 CMS
Janssen Biotech, Inc. $20.6009/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174979674 CMS
Takeda Pharmaceuticals U.S.A., Inc. $25.6409/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223900261 CMS
BeOne Medicines USA, Inc. $24.8109/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202885176 CMS
ARRAY BIOPHARMA INC $24.9808/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1230481120 CMS
Eisai Inc. $27.3508/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1244476726 CMS
BeOne Medicines USA, Inc. $31.8308/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202885184 CMS
Regeneron Healthcare Solutions, Inc. $32.4108/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1212955934 CMS
ARRAY BIOPHARMA INC $21.2808/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229903562 CMS
Celgene Corporation $24.6408/20/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184894408 CMS
E.R. Squibb & Sons, L.L.C. $20.5308/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184894566 CMS
E.R. Squibb & Sons, L.L.C. $1.7008/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1184894568 CMS
EMD Serono, Inc. $22.7908/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236908441 CMS
Novartis Pharmaceuticals Corporation $17.6308/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200312108 CMS
GlaxoSmithKline, LLC. $27.4708/15/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1191113270 CMS
Exelixis Inc. $28.0408/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218793661 CMS
Genentech USA, Inc. $25.1608/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211509232 CMS
Sumitomo Pharma America, Inc. $24.1808/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1176673453 CMS
Gilead Sciences, Inc. $28.3808/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234448751 CMS
PFIZER INC. $15.7508/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229658539 CMS
TAIHO ONCOLOGY, INC. $15.7908/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1211408489 CMS
GENZYME CORPORATION $16.7907/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1233288263 CMS
ADC THERAPEUTICS AMERICA, INC. $21.9707/30/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1246112290 CMS
PFIZER INC. $20.1207/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229559148 CMS
AstraZeneca Pharmaceuticals LP $19.8307/24/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1207208517 CMS
PFIZER INC. $20.9207/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229527199 CMS
Agios Pharmaceuticals, Inc. $22.5807/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1253258485 CMS
Exelixis Inc. $24.3807/21/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1218793659 CMS
Coherus Oncology, Inc. $22.8507/11/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1235236049 CMS
PFIZER INC. $11.9307/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1229516510 CMS
Astellas Pharma US Inc $18.3107/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238803746 CMS
Janssen Biotech, Inc. $27.0207/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1174980152 CMS
BeOne Medicines USA, Inc. $21.0907/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1202885190 CMS
Novartis Pharmaceuticals Corporation $18.8207/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1200312104 CMS
Takeda Pharmaceuticals U.S.A., Inc. $15.3907/01/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223821626 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $97,290.65 181
PY2020 $8,367.28 71
PY2021 $10,013.36 74
PY2022 $28,897.52 109
PY2023 $10,711.94 162
PY2024 $35,587.41 215
PY2025 $9,650.92 198

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $6,490.00 15
PY2024 Principal investigator $930.17 1
PY2023 Principal investigator $0.01 1
PY2022 Principal investigator $40,763.80 5
PY2021 Principal investigator $39,703.40 6
PY2020 Principal investigator $28,100.36 11
PY2019 Principal investigator $15,605.76 5

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

15 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 GlaxoSmithKline, LLC. $1,923.75 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167840
Principal investigator 1 GlaxoSmithKline, LLC. $68.85 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167844
Principal investigator 1 GlaxoSmithKline, LLC. $150.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167848
Principal investigator 1 GlaxoSmithKline, LLC. $125.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167852
Principal investigator 1 GlaxoSmithKline, LLC. $250.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167856
Principal investigator 1 GlaxoSmithKline, LLC. $750.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167861
Principal investigator 1 GlaxoSmithKline, LLC. $250.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167865
Principal investigator 1 GlaxoSmithKline, LLC. $250.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192167869
Principal investigator 1 GlaxoSmithKline, LLC. $148.50 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168725
Principal investigator 1 GlaxoSmithKline, LLC. $150.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168729
Principal investigator 1 GlaxoSmithKline, LLC. $925.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168732
Principal investigator 1 GlaxoSmithKline, LLC. $549.45 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168737
Principal investigator 1 GlaxoSmithKline, LLC. $150.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168741
Principal investigator 1 GlaxoSmithKline, LLC. $549.45 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168744
Principal investigator 1 GlaxoSmithKline, LLC. $250.00 09/30/2025 Non-covered Recipient Entity
EASTERN CONNECTICUT HEMATOLOGY AND ONCOLOGY ASSOCIATES
A RANDOMIZED, OPEN LABEL PHASE 2/3 STUDY COMPARING COBOLIMAB + DOSTARL No dispute reported 06/30/2026 1192168748